Search

Search Constraints

You searched for: Author/Creator Chan, Wing C.

Search Results

1. 27: Province-Wide Analysis of Patient Reported Outcomes for Stage IV Non-Small Cell Lung Cancer. (October 2021)

2. B‐cell lymphoma, unclassifiable, with features intermediate between diffuse large B‐cell lymphoma and burkitt lymphoma: study of 39 cases. (18th April 2013)

3. CCL3 and CCL4 are biomarkers for B cell receptor pathway activation and prognostic serum markers in diffuse large B cell lymphoma. (11th September 2015)

4. CD43 expression is associated with inferior survival in the non‐germinal centre B‐cell subgroup of diffuse large B‐cell lymphoma. (25th April 2013)

5. Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue Sites. (June 2016)

7. EBV‐positive HIV‐associated diffuse large B cell lymphomas are characterized by JAK/STAT (STAT3) pathway mutations and unique clinicopathologic features. (17th July 2021)

8. Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall. (May 2020)

9. Gene Expression Signatures for the Accurate Diagnosis of Peripheral T-Cell Lymphoma Entities in the Routine Clinical Practice. Issue 36 (20th December 2022)